반응식
[CH3:1][C:2]1([CH3:16])[C:11]2[C:6](=[CH:7][C:8]([C:12](=[O:14])[CH3:13])=[CH:9][CH:10]=2)[C:5](=O)[CH2:4][CH2:3]1.C[C:18]1(C)[C:27]2[C:22](=CC(Br)=CC=2)[C:21]([S:29]C2C=CC=CC=2)=[CH:20][CH2:19]1>>[CH3:1][C:2]1([CH3:16])[C:11]2[C:6](=[CH:7][C:8]([C:12](=[O:14])[CH3:13])=[CH:9][CH:10]=2)[C:5]([S:29][C:21]2[CH:22]=[CH:27][CH:18]=[CH:19][CH:20]=2)=[CH:4][CH2:3]1참가 물질
3
실험 절차
Employing the procedure used for the preparation of 4,4-dimethyl-7-acetyl-3,4-dihydronaphthalen-1(2H)-one (Compound C1) 1.2 g, (3.5 mmol) of 4,4-dimethyl-7-Bromo-1-phenylthio-3,4-dihydronaphthalene (Compound A35) was converted to the title compound.
출처 및 근거
- ORD 기록
- ord-7ac6f5c6953746b4bac3956fd81beed3
- 출처 데이터셋
- uspto-grants-2005_02
- 특허 번호
- US06855832B2
연결된 노트
불러오는 중…